VITREX MEDICAL A/S: Financial statements 2014
CVR: 14728732
Source: annual report 2014, Danish Business Authority
01/05/2013 – 30/04/2014
VITREX MEDICAL A/S (CVR 14728732) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 16,035,034 and a net result of DKK 4,611,403 compared with DKK 3,881,800 the year before. That is an increase of 9.3% compared with the year before. Equity in the 2014 report amounted to DKK 17,880,936. The solvency ratio was 55.7%.
- Gross Profit
- DKK 16,035,034
- Profit/Loss
- DKK 4,611,403
- Equity
- DKK 17,880,936
- Total Assets
- DKK 32,106,810
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of December 30, 2014, is registered as an owner of VITREX MEDICAL A/S with an ownership share of 100%.
As of February 21, 2014, Teodor Lysák has joined the board of directors of VITREX MEDICAL A/S.
As of February 21, 2014, Michal Staron has joined the board of directors of VITREX MEDICAL A/S.
As of February 21, 2014, Marek Herold has joined the board of directors of VITREX MEDICAL A/S.
As of February 21, 2014, Per Hugo Thomsen has left the board of directors of VITREX MEDICAL A/S.
As of February 21, 2014, Ditte Valentin Meincke has left the board of directors of VITREX MEDICAL A/S.
As of February 21, 2014, Søren Valentin Stentoft has left the board of directors of VITREX MEDICAL A/S.
As of February 21, 2014, Vagn Andersen has left the board of directors of VITREX MEDICAL A/S.
About VITREX MEDICAL A/S
VITREX MEDICAL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1990. The company is registered under the industry Fremstilling og bearbejdning af andet glas, herunder teknisk glas. The company was previously named MODULOHM A/S and A/S PSE NR. 4106. The management consists of Anders Folkmar Pedersen. The board consists of Michal Staron (chair), Marcin Sieczek and Vagn Andersen. The company is owned by CHIRANA T.Injecta, a. s.. The company has 60 employees (2026). In 2025, the company reported a gross profit of DKK 34,669,165 and a net result of DKK 6,179,533 compared with DKK 1,819,121 the year before. Equity in the 2025 report amounted to DKK 42,246,689.